CURIS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CURIS, INC. (CRIS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.77 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-03
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$1.77M, a 9950.00% decline year-over-year.
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $4.93M, a 75.60% decline year-over-year.
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$6.01M, a 217.26% decline year-over-year.
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $18.00K.
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.43M, a 139.50% decline from fiscal 2014.
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $16.27M.
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$13.62M.
- CURIS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$23.00M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | -$1.77M 10-Q · filed 2018-05-03 | ||||||
| 2017-09-30 | $4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.08M derived: sum of 2 quarters · filed 2017-11-07 | -$1.06M 10-Q · filed 2017-11-07 | ||||
| 2017-06-30 | -$6.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$5.99M 10-Q · filed 2017-08-03 | |||||
| 2017-03-31 | $18.00K 10-Q · filed 2018-05-03 | ||||||
| 2016-09-30 | $20.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $25.35M derived: sum of 2 quarters · filed 2017-11-07 | $16.06M 10-Q · filed 2017-11-07 | $31.72M derived: sum of 4 quarters · filed 2017-11-07 | |||
| 2016-06-30 | $5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$4.16M 10-Q · filed 2017-08-03 | $11.50M derived: sum of 3 quarters · filed 2017-08-03 | $14.26M derived: sum of 4 quarters · filed 2017-08-03 | |||
| 2016-03-31 | -$9.29M 10-Q · filed 2017-05-04 | -$9.29M 10-Q · filed 2016-05-09 | $6.37M derived: sum of 2 quarters · filed 2017-05-04 | $9.13M derived: sum of 3 quarters · filed 2017-05-04 | $24.86M derived: sum of 4 quarters · filed 2017-05-04 | ||
| 2015-12-31 | $15.66M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $18.43M derived: sum of 2 quarters · filed 2016-11-03 | $34.15M derived: sum of 3 quarters · filed 2016-11-03 | -$6.43M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $18.49M derived: sum of 2 quarters · filed 2016-11-03 | -$22.09M 10-Q · filed 2016-11-03 | -$22.09M 10-Q · filed 2015-11-09 | -$16.84M derived: sum of 4 quarters · filed 2016-11-03 | ||
| 2015-06-30 | $15.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$24.85M 10-Q · filed 2016-08-04 | -$24.85M 10-Q · filed 2015-08-06 | -$19.60M derived: sum of 3 quarters · filed 2016-08-04 | -$18.92M derived: sum of 4 quarters · filed 2016-08-04 | ||
| 2015-03-31 | -$40.58M 10-Q · filed 2016-05-09 | -$35.33M derived: sum of 2 quarters · filed 2016-05-09 | -$34.65M derived: sum of 3 quarters · filed 2016-05-09 | -$27.75M derived: sum of 4 quarters · filed 2016-05-09 | |||
| 2014-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.93M derived: sum of 2 quarters · filed 2016-02-29 | $12.83M derived: sum of 3 quarters · filed 2016-02-29 | $16.27M 10-K · filed 2016-02-29 | |||
| 2014-09-30 | $675.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $7.58M derived: sum of 2 quarters · filed 2015-11-09 | $11.02M 10-Q · filed 2015-11-09 | $5.09M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $10.34M 10-Q · filed 2015-08-06 | $4.42M derived: sum of 3 quarters · filed 2016-02-29 | -$1.65M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $3.44M 10-Q · filed 2015-05-07 | -$2.49M derived: sum of 2 quarters · filed 2016-02-29 | -$8.55M derived: sum of 3 quarters · filed 2016-02-29 | -$11.44M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$11.99M derived: sum of 2 quarters · filed 2016-02-29 | -$14.88M derived: sum of 3 quarters · filed 2016-02-29 | -$13.62M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$6.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$8.95M derived: sum of 2 quarters · filed 2014-11-10 | -$7.69M 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | -$2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$1.63M 10-Q · filed 2014-08-07 | |||||
| 2013-03-31 | $1.26M 10-Q · filed 2014-05-09 | ||||||
| 2012-12-31 | -$23.00M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |